Clinical Research Directory
Browse clinical research sites, groups, and studies.
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
Sponsor: GlaxoSmithKline
Summary
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).
Official title: A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2) - China Extension
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2025-11-21
Completion Date
2028-06-02
Last Updated
2026-06-16
Healthy Volunteers
No
Conditions
Interventions
BLU-5937
Oral administration of BLU-5937 Tablets.
Placebo
Oral administration of matching placebo for BLU-5937 Tablets.
Locations (38)
GSK Investigational Site
Leshan, Sichuan, China
GSK Investigational Site
Beijing, China
GSK Investigational Site
Changsha, China
GSK Investigational Site
Chengdu, China
GSK Investigational Site
Chengdu, China
GSK Investigational Site
Chongqing, China
GSK Investigational Site
Dongguan, China
GSK Investigational Site
Ganzhou, China
GSK Investigational Site
Guangzhou, China
GSK Investigational Site
Guangzhou, China
GSK Investigational Site
Guilin, China
GSK Investigational Site
Hangzhou, China
GSK Investigational Site
Hefei, China
GSK Investigational Site
Hefei, China
GSK Investigational Site
Hohhot, China
GSK Investigational Site
Huizhou, China
GSK Investigational Site
Huizhou, China
GSK Investigational Site
Jiangsu, China
GSK Investigational Site
Jinan, China
GSK Investigational Site
Kunming, China
GSK Investigational Site
Liuzhou, China
GSK Investigational Site
Meizhou, China
GSK Investigational Site
Nanchang, China
GSK Investigational Site
Pingxiang, China
GSK Investigational Site
Shanghai, China
GSK Investigational Site
Shanghai, China
GSK Investigational Site
Shanghai, China
GSK Investigational Site
Shenyang, China
GSK Investigational Site
Shenzhen, China
GSK Investigational Site
Taizhou, China
GSK Investigational Site
Ürümqi, China
GSK Investigational Site
Weifang, China
GSK Investigational Site
Wuxi, China
GSK Investigational Site
Xiamen, China
GSK Investigational Site
Yangzhou, China
GSK Investigational Site
Yinchuan, China
GSK Investigational Site
Zhanjiang, China
GSK Investigational Site
Zhengzhou, China